Literature DB >> 19086882

Memory loss in Alzheimer's disease: implications for development of therapeutics.

Carl A Gold1, Andrew E Budson.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by a constellation of cognitive disturbances, the earliest and most prominent being impaired episodic memory. Episodic memory refers to the memory system that allows an individual to consciously retrieve a previously experienced item or episode of life. Many recent studies have focused on characterizing how AD pathology impacts particular aspects of episodic memory and underlying mental and neural processes. This review summarizes the findings of those studies and discusses the effects of current and promising treatments for AD on episodic memory. The goal of this review is to raise awareness of the strides that cognitive neuroscientists have made in understanding intact and dysfunctional memory. Knowledge of the specific memorial processes that are impaired in AD may be of great value to basic scientists developing novel therapies and to clinical researchers assessing the efficacy of those therapies.

Entities:  

Mesh:

Year:  2008        PMID: 19086882      PMCID: PMC2655107          DOI: 10.1586/14737175.8.12.1879

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  101 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.

Authors:  Ricardo F Allegri; Judith Butman; Raúl L Arizaga; Gerardo Machnicki; Cecilia Serrano; Fernando E Taragano; Diego Sarasola; Leandro Lon
Journal:  Int Psychogeriatr       Date:  2006-07-27       Impact factor: 3.878

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

5.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

6.  Provoked confabulations in Alzheimer's disease.

Authors:  Janine M Cooper; Michael F Shanks; Annalena Venneri
Journal:  Neuropsychologia       Date:  2006-05-11       Impact factor: 3.139

7.  Semantic priming in patients with Alzheimer and semantic dementia.

Authors:  H Nakamura; M Nakanishi; T Hamanaka; S Nakaaki; S Yoshida
Journal:  Cortex       Date:  2000-04       Impact factor: 4.027

8.  The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Authors:  C Holmes; D Wilkinson; C Dean; S Vethanayagam; S Olivieri; A Langley; N D Pandita-Gunawardena; F Hogg; C Clare; J Damms
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

9.  Preserved neural correlates of priming in old age and dementia.

Authors:  Cindy Lustig; Randy L Buckner
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

10.  Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia.

Authors:  D J Libon; B Bogdanoff; B S Cloud; S Skalina; T Giovannetti; H L Gitlin; J Bonavita
Journal:  J Clin Exp Neuropsychol       Date:  1998-02       Impact factor: 2.475

View more
  44 in total

1.  Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment.

Authors:  Brandon A Ally; Erin P Hussey; Philip C Ko; Robert J Molitor
Journal:  Hippocampus       Date:  2013-08-14       Impact factor: 3.899

2.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

Review 3.  Clinical utility of resting-state functional connectivity magnetic resonance imaging for mood and cognitive disorders.

Authors:  T Takamura; T Hanakawa
Journal:  J Neural Transm (Vienna)       Date:  2017-03-23       Impact factor: 3.575

4.  Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Authors:  Dave J Koss; Lianne Robinson; Anna Mietelska-Porowska; Anna Gasiorowska; Kristina Sepčić; Tom Turk; Marcel Jaspars; Grazyna Niewiadomska; Roderick H Scott; Bettina Platt; Gernot Riedel
Journal:  Cell Mol Life Sci       Date:  2015-06-13       Impact factor: 9.261

5.  Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.

Authors:  Tanusree Sen; Pampa Saha; Tong Jiang; Nilkantha Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-12       Impact factor: 11.205

Review 6.  Obesity and episodic memory function.

Authors:  Paul D Loprinzi; Emily Frith
Journal:  J Physiol Sci       Date:  2018-04-17       Impact factor: 2.781

7.  Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity.

Authors:  Azam Almasi; Mohammad Zarei; Safoura Raoufi; Abdolrahman Sarihi; Iraj Salehi; Alireza Komaki; Nasrin Hashemi-Firouzi; Siamak Shahidi
Journal:  Metab Brain Dis       Date:  2018-07-23       Impact factor: 3.584

Review 8.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 9.  Vascular cognitive impairment.

Authors:  Muhammad U Farooq; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

Review 10.  Using pictures and words to understand recognition memory deterioration in amnestic mild cognitive impairment and Alzheimer's disease: a review.

Authors:  Brandon A Ally
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.